8:30 AM – Doors Open

• Badge pickup, registration and breakfast
• In-person meetings begin (as scheduled via Meetmax)

09.00 -10.00 AM 
Nordic SME Program - Explore the US Healthcare Market & Lion’s Den Pitching, Hosted by Innovation Norway.

This is a great opportunity to join Innovation Norway’s US Healthcare market team and partners at Nordic-American Healthcare Conference for an insightful exploration of the US Market Overview, and an unparalleled opportunity to present ideas to a panel of esteemed investors in our Lion's Den/Investor panel.

- 5 minute pitch to the lions
- Immediate unfiltered feedback
- Networking opportunity

9:00 – 10:00 AM
Nordic CEO Workshop – Critical Issues and Challenges in Crossing the Pond & Fireside Chat with Palette Life Sciences (by invitation) 

Moderated by Jonathan Gertler, CEO, Back Bay Life Science Advisors, and Vasilios Kofitsas, Managing Director, Investment Banking, Back Bay Life Science Advisors

10:15 – 10:30 AM
Welcome Remarks - Anne Grabe and Jonathan Gertler, DNB//Back Bay Partnership for Healthcare

10:30 – 11:00 AM
Financing and M&A Dynamics in the Current Markets (Panel Discussion)

• James Cirenza, Managing Director, DNB Markets
• Patrick Moriarty, Executive Director, Business Development, Merck
• Ilir Mujalovic, Partner, Shearman & Sterling
• Carsten Borring, Head of Listings and Capital Markets, Nasdaq Copenhagen
• Moderated by:Gregory Benning, Managing Director, Head of Investment Banking, Back Bay Life Science Advisors

11:00 – 11:30 AM
Delivering Healthcare in the US Market (Keynote Address)

• Marcela G. del Carmen, MD, MPH
  Professor of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School
  President, Massachusetts General Physicians Organization
  Executive Vice President, Mass General Brigham

11:30 – 11:45 AM
Networking Break

11:45 – 12:45 PM
Company Presentations by: 

• Alligator Bioscience – Soren Bregenholt, CEO
• BioArctic – Oskar Bosson, Vice President, Investor Relations
• Cereno Scientific - Sten Sörensen, CEO
• Cantargia, Göran Forsberg, CEO

Moderated by Peter Bak, Managing Director, Healthcare Strategy, Back Bay Life Science Advisors

12:45 – 1:45 PM
Networking Lunch

1:45 – 2:15 PM
Technology and Strategic Challenges in Treatment Development (Panel Discussion)

• Gareth Hicks, Vice President & Head of Gastrointestinal Drug Discovery, Takeda
• Alison Schecter, CMO, Head of R&D, Axcella, Sarepta, Sanofi
• Patrick Moriarty, Executive Director, Business Development, Merck
• Moderated bySteve Gauldie, Managing Director, Healthcare Strategy and Investment Banking, Back Bay Life Science Advisors

2:15 – 3:30 PM
Company Presentations by: 

• Photocure – Dan Schneider, CEO
• Bactolife – Sebastian Søderberg, CEO
• UNEEG Medical – Torben Sandgren, CEO
• AlzeCure Pharma - Martin Jönsson, CEO
• Initiator Pharma – Claus Olesen, CEO  

Moderated by Christopher Leo, Managing Director, Healthcare Strategy, Back Bay Life Science Advisors

3:30 – 3:45
Networking Break

3:45– 4:30 PM
Company Presentations by:

• Oncoinvent- Anders Månsson, CEO
• Evosep – Ole Vorm, CEO 
• Synklino – Thomas N. Kledal, CEO  

Moderated by Maha Malik, Investment Banking Associate Director, DNB Markets

4:30 – 5:00 PM
Integrating and Commercializing Healthcare Technology into US IDNs (Panel and Happy Hour)

• Gaye Bok, Partner, AI and Digital Innovation Fund, Mass General Brigham
• Blake Marggraff, CEO, Lightbeam Health Solutions
• Homer Pien, Former Chief Scientific Officer, Philips
• Moderated byJonathan Gertler, CEO, Back Bay Life Science Advisors 

5:00 – 6:30 PM
Closing Remarks and Reception

Thank you for joining us for day one of the Nordic-American Healthcare Conference. Please join us for day two and hear from companies like Novo Nordisk, Sobi and more.

Presentation times are subject to change. For questions, please contact: healthcarepartnership@bblsa.com

8:30 AM – Doors Open

• Badge pickup, registration and breakfast
• In-person meetings begin (as scheduled via Meetmax)

9:00 – 9:15 AM
Welcome Remarks

Welcome remarks by Ted Jadick, President/CEO DNB Markets Inc. and Vidar Andersen Head of DNB North America

9:15 - 12:45 AM Company Presentations and networking

9:15 – 9:40 AM
Company Presentation: XVIVO

9:40 – 10:05 AM
Company Presentation: ULTIMOVACS

10:05 – 10:30 AM
Company Presentation: ALK ABELLO

10:30 – 10:45 AM
Networking Break

10:45 – 11:10 AM
Company Presentation: SOBI

11:10 – 11:35 AM
Company Presentation: ALVOTECH

11:35 – 12:00 PM
Company Presentation: NOVO NORDISK

12:00 – 12:45 PM
Networking Lunch, 1x1 Meetings

12:45 – 1:30 PM Panel Discussion

Global Healthcare Capital Markets: Where are we and where are we headed?

Participants:

• Jonathan Andersson, Equity Research Analyst – Healthcare, DNB Markets (Stockholm)
• Greg Benning, Managing Director & Group Head Investment Banking, Back Bay Life Science Advisors (Boston)
• Carsten Borring, AVP Global Listing, Nasdaq (Copenhagen)
• Rune Dahl, Senior Equity Research Analyst – Healthcare, DNB Markets (Copenhagen)
• Patrik Ling, Senior Equity Research Analyst – Healthcare, DNB Markets (Stockholm)
• Sebastian Intveen, Director – Healthcare Investment Banking, DNB Markets (Oslo)

Moderated by Andreas Dirnagl, Senior Advisor – Healthcare, DNB Bank ASA (NY)

1:30 - 1:45
Networking break

1:45 - 3:00 Company Presentations

1:45 – 2:10 PM
Company Presentation: CALLIDITAS

2:10 – 2:35 PM
Company Presentation: BIOARCTIC

2:35 – 3:00 PM
Company Presentation: BAVARIAN NORDIC

3:00 – 5:30 PM Closing Remarks and Reception

Presentation times are subject to change. For questions, please contact: healthcarepartnership@bblsa.com